VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 26 filers reported holding VASCULAR BIOGENICS LTD in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $32 | -99.9% | 264,500 | -20.5% | 0.00% | – |
| Q3 2022 | $52,000 | -65.8% | 332,600 | +338.8% | 0.00% | – |
| Q1 2021 | $152,000 | -84.5% | 75,800 | -85.4% | 0.00% | -100.0% |
| Q4 2020 | $979,000 | +30.9% | 518,200 | -15.5% | 0.00% | 0.0% |
| Q3 2020 | $748,000 | -3.1% | 613,047 | +1.6% | 0.00% | 0.0% |
| Q2 2020 | $772,000 | +295.9% | 603,133 | +317.1% | 0.00% | – |
| Q1 2020 | $195,000 | +353.5% | 144,600 | +306.0% | 0.00% | – |
| Q4 2019 | $43,000 | +65.4% | 35,615 | +81.6% | 0.00% | – |
| Q3 2019 | $26,000 | -42.2% | 19,612 | -43.8% | 0.00% | – |
| Q2 2019 | $45,000 | +114.3% | 34,900 | +149.3% | 0.00% | – |
| Q1 2019 | $21,000 | -70.8% | 14,000 | -68.5% | 0.00% | – |
| Q3 2018 | $72,000 | – | 44,401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,593,286 | $5,108,000 | 1.37% |
| Ikarian Capital, LLC | 790,838 | $1,558,000 | 0.23% |
| Telemetry Investments, L.L.C. | 70,000 | $138,000 | 0.18% |
| PVG ASSET MANAGEMENT CORP | 12,365 | $24,359,000 | 0.09% |
| DLD Asset Management, LP | 425,000 | $837,000 | 0.04% |
| Phoenix Holdings Ltd. | 1,020,000 | $2,009,000 | 0.03% |
| Spectrum Planning & Advisory Services Inc. | 16,000 | $32,000 | 0.03% |
| ARK Investment Management | 1,330,206 | $2,621,000 | 0.01% |
| Harel Insurance Investments & Financial Services Ltd. | 194,000 | $382,000 | 0.01% |
| Total Clarity Wealth Management, Inc. | 4,000 | $8,000 | 0.00% |